DaVita HealthCare Partners Forecast, price target & analysts
DaVita HealthCare Partners Target price 2025 - Analyst rating & recommendation
DaVita HealthCare Partners Classifications & Recommendation:
DaVita HealthCare Partners Price Target
| Target Price | $151.58 |
| Price | $123.60 |
| Potential |
22.64%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target DaVita HealthCare Partners 2026 .
The average DaVita HealthCare Partners target price is $151.58.
This is
22.64%
register free of charge
$195.30
58.01%
register free of charge
$138.37
11.95%
register free of charge
|
|
| A rating was issued by 17 analysts: 1 Analysts recommend DaVita HealthCare Partners to buy, 10 to hold and 6 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the DaVita HealthCare Partners stock has an average upside potential 2026 of
22.64%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 12.82 | 13.62 |
| 5.56% | 6.24% | |
| EBITDA Margin | 20.90% | 20.66% |
| 8.14% | 1.16% | |
| Net Margin | 7.31% | 5.76% |
| 28.26% | 21.16% |
11 Analysts have issued a sales forecast DaVita HealthCare Partners 2025 . The average DaVita HealthCare Partners sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an DaVita HealthCare Partners EBITDA forecast 2025. The average DaVita HealthCare Partners EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 DaVita HealthCare Partners Analysts have issued a net profit forecast 2025. The average DaVita HealthCare Partners net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 10.73 | 11.06 |
| 44.61% | 3.08% | |
| P/E | 11.18 | |
| EV/Sales | 1.34 |
11 Analysts have issued a DaVita HealthCare Partners forecast for earnings per share. The average DaVita HealthCare Partners EPS is
This results in the following potential growth metrics and future valuations:
DaVita HealthCare Partners...
Current DaVita HealthCare Partners Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| TD Cowen |
Locked
➜
Locked
|
Locked | Nov 03 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 30 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 09 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Sep 10 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | May 19 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Feb 18 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
TD Cowen:
Locked
➜
Locked
|
Nov 03 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 30 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 09 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Sep 10 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Aug 07 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
May 19 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 18 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
